01 /What the Khavinson framework is
Beginning in the 1970s, a Russian research group led by Vladimir Khavinson described a category of short peptides (typically 2 to 4 amino acids) that they proposed act as tissue specific bioregulators. The framework holds that very short peptides, often derived from organ tissue extracts or modeled on sequences found in those extracts, signal selectively to the cell populations of the originating tissue.
The research base is primarily Russian language with smaller publication in international journals. The framework remains less established in Western literature than the receptor pharmacology framework that dominates most peptide research, but the published work is real and the compounds are commercially synthesized worldwide.
02 /Why so many compounds
The Khavinson series includes dozens of named peptides, each proposed to act on a different tissue. Apothify lists the most commonly studied subset: Epitalon (pineal), Cortagen (cerebral cortex), Cortexin (cerebral cortex), Pinealon (pineal), Vesugen (vascular), Cerebrolysin (brain hydrolysate, related family), Suprefort (pancreas), Bronchogen (bronchial), Cardiogen (cardiac), Livagen (liver), Vilon (thymic), Crystagen (thymic), Ovagen (liver), Chonluten (bronchial), Thymogen (thymic), Sigumir (cartilage), Visoluten (ocular), Ventfort (vascular), Endoluten (pineal), Cerluten (brain), Stamakort (gastric), and Bonothyrk (parathyroid).
Each is described in Russian language research as targeting a different tissue. The sequences are typically tripeptides or tetrapeptides; some are dipeptides. The Apothify library lists each separately with the sequence where it is publicly documented.
03 /The most commonly searched entries
Epitalon (Ala-Glu-Asp-Gly) is the highest profile compound in the family. It is studied in telomere, circadian rhythm, and aging research models. Apothify lists Epitalon as ELEVATED with warning level 2.
Cortagen (Ala-Glu-Asp-Pro), Cortexin (a polypeptide complex from cortical tissue), and Pinealon (Glu-Asp-Arg) are commonly studied in cognition and neuroprotection research contexts.
Thymogen (Glu-Trp) and the related thymic peptides (Vilon, Crystagen) are studied in immune research contexts adjacent to the synthetic thymic peptide family.
04 /How the family sits in the Apothify library
The full Khavinson series is presented in the Apothify library, distributed across the longevity, cognition, healing recovery, and immunity categories based on the tissue each peptide targets. Most entries are SAFE; some are ELEVATED.
The SAFE entries in the Khavinson series carry product SKUs in the Apothify catalog. These are typically 20 milligram lyophilized vials at moderate price points reflecting their commercial availability through specialty research suppliers.
The ELEVATED entries are encyclopedia only and exist for library completeness.
05 /How they interact with each other
The Apothify interaction matrix includes several Khavinson pairings. Vesugen plus Epitalon is flagged as synergy in circadian and longevity research contexts. Cortagen plus BPC-157 is flagged in gut research. Endoluten plus Pinealon is flagged as synergy in pineal research. Several cross tissue pairings are flagged as synergy where the literature has documented combined study.
Russian bioregulators do not have a strong cross family interaction profile in the Western literature; the framework classifies each peptide as tissue specific, so combinations across tissues are studied as additive rather than synergistic in the receptor sense.
06 /What the framework does and does not claim
The Khavinson framework claims tissue specific signaling. It claims that short peptides derived from organ extracts can selectively engage the corresponding cell populations.
It does not claim broad disease treatment, and the Apothify entries follow the standard research framing. Each entry uses the same six section structure and the same safety language as the rest of the library.
The framework is not the standard model for peptide pharmacology in Western literature. Researchers familiar with receptor pharmacology may find the mechanistic descriptions in the Khavinson literature less specific than they expect.
07 /Sequence transparency
Apothify lists the sequence where it is publicly documented in the literature. For some entries the sequence is unambiguous (Epitalon, Vesugen, Cortagen). For others the published sequence is less commonly cited and the entry frames the compound by name and family rather than by exact sequence.
Where the sequence is uncertain, Apothify defers to the convention used in the most commonly cited published source. Researchers seeking absolute sequence certainty should reach out to the manufacturer that synthesized their specific lot.
08 /Where to read more
The Khavinson research group has published widely in Russian journals; English language overviews are available in several aging research reviews. The Apothify pages summarize the published literature in the standard six section format and link to related peptides where the compare tool can put them side by side.
For the wider context of short peptide research, the bioregulator framework sits adjacent to but separate from receptor pharmacology approaches. Researchers benefit from reading both frameworks to triangulate.
